2nd Quarter - Report — SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC. (2012)

Firm

SMITH & NEPHEW, INC.

Client

SMITH & NEPHEW, INC.

Income

—

Expenses

$260,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 436 (112th), S. 17 (112th)

Medicare/Medicaid MMM

Durable Medical Equipment (DME) Rule for the Medicare program, first published on July 8, 2011. DME competitive bidding.

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Spec. Assist, HHS; Counsel, Sen. Budget Com.

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Provisions related to medical devices in the "Food and Drug Administration Safety and Innovation Act," P.L. 112-144.

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.